Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.
Traditional Chinese medicine for treatment of hyperosteogeny and spondylopathy
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for bone hyperplasia and spondylosis, applied in bone diseases, drug combinations, pharmaceutical formulations, etc., can solve the problems of easy recurrence, high cost, long recovery period, etc., to improve muscle tension, simple production, and improved function. Effect
Active Publication Date: 2015-04-01
周杰山
View PDF3 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0006] The object of the present invention is to provide a kind of Chinese medicine for treating hyperosteogeny and spondylosis, which can effectively solve the problem of slow curative effect, easy recurrence, poor effect, high cost, high cost and large trauma when treating hyperosteogeny and spondylosis. Long recovery period and recurring problems
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment Construction
[0018] The following examples and implementation methods are for further illustrating the present invention, rather than limiting the present invention.
[0019] A traditional Chinese medicine for treating hyperosteogeny and spondylosis, made of the following raw materials: Duhuo 8-10g, Clematis 9-11g, Dinggongteng 3-5g, Tripterygium 3-5g, Shengchuanwu 3- 5 g, 4-6 g of saffron, 4-6 g of Shanzi mushroom, 4-6 g of red bud euphorbia, 5-8 g of redbud skin, 4-6 g of rhubarb, 8-10 g of Xu Changqing, 3 yuan of earth element -5 g, frankincense 10 g, myrrh 9-11 g, acacia 3-5 g, chuanduan 9-11 g, pepper 9-11 g, camphor 3-5 g, liquor 400-600 g.
[0020] A traditional Chinese medicine for treating hyperosteogeny and spondylosis, made from the following raw materials: Duhuo 8-10 g, Clematis 10 g, Dinggongteng 3-5 g, Tripterygium wilfordii 3-5 g, Shengchuanwu 3-5 g, 5 g saffron, 5 g shanzi mushroom, 5 g red bud euphorbia, 5-8 g bauhinia skin, 5 g rhubarb, 8-10 g Xu Changqing, 3-5 g earth e...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a traditional Chinese medicine for treatment of hyperosteogeny and spondylopathy, and especially for treatment of cervical spondylosis. The traditional Chinese medicine comprises the following crude drugs by weight: radix angelicae pubescentis, radix clematidis, Caulis Erycibes, Tripterygium wilfordii, crude Sichuan aconite roots, Stigma Croci, pleione rhizome, Knoxia valerianoides Thorel ex Pitard, Chinese redbud bark, rhubarb, Xu Changqing, ground beetles, frankincense, myrrh, gleditsia sinensis, dipsacus roots, Chinese prickly ash, camphor and white spirit. The traditional Chinese medicine can effectively solve the problems of slow curative effect, easy relapse, undesirable effect, high risk, expensive cost, great trauma, long recovery period and easy recurrence during treatment of hyperosteogeny and spondylopathy. With obvious curative effects on hyperosteogeny and spondylopathy, the traditional Chinese medicine can alleviate symptoms and improve functions at the earlier stage, and at the later stage, can enhance the muscle tension, improve and correct abnormal functions, as well as strengthen ligament elasticity.
Description
technical field [0001] The invention relates to a traditional Chinese medicine for treating hyperosteogeny and spondylosis, especially a traditional Chinese medicine for treating cervical spondylosis. Background technique [0002] Hyperosteogeny is a kind of frequently-occurring disease, common disease. Hyperosteogeny is a common and frequently-occurring disease in middle-aged and elderly people. It is mainly named as osteoarthritis, osteoarthritis, hypertrophic osteoarthritis, and degenerative osteoarthritis abroad. The main names of Chinese medicine include osteoarthropathy, intervertebral disc degeneration, proliferative arthritis, bone and joint degenerative disease, bone spurs, etc., while Chinese medicine belongs to the scope of arthralgia. [0003] Spondylosis is the occurrence of lesions in the bones, intervertebral discs, ligaments, and muscles of the spine, which in turn compress and stimulate the spinal cord, spinal nerves, blood vessels, and autonomic nerves, r...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.